SEI Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-21,047
| Closed | -$7.55K | – | 2752 |
|
|
2024
Q2 | $7.55K | Hold |
21,047
| – | – | ﹤0.01% | 2650 |
|
|
2024
Q1 | $14.1K | Hold |
21,047
| – | – | ﹤0.01% | 2606 |
|
|
2023
Q4 | $11.4K | Sell |
21,047
-20,138
| -49% | -$9.28K | ﹤0.01% | 2602 |
|
|
2023
Q3 | $24.7K | Sell |
41,185
-9,433
| -19% | -$10.1K | ﹤0.01% | 2593 |
|
|
2023
Q2 | $65.8K | Buy |
50,618
+26,897
| +113% | +$36.7K | ﹤0.01% | 2599 |
|
|
2023
Q1 | $41.7K | Buy |
23,721
+2,976
| +14% | +$8.49K | ﹤0.01% | 2639 |
|
|
2022
Q4 | $65.2K | Sell |
20,745
-98
| -0.5% | -$380 | ﹤0.01% | 2471 |
|
|
2022
Q3 | $102K | Buy |
+20,843
| New | +$107K | ﹤0.01% | 2564 |
|
|
2022
Q2 | – | Sell |
-20,635
| Closed | -$61K | – | 2712 |
|
|
2022
Q1 | $61K | Buy |
20,635
+299
| +1% | +$1.78K | ﹤0.01% | 2541 |
|
|
2021
Q4 | $98K | Sell |
20,336
-512
| -2% | -$4.45K | ﹤0.01% | 2541 |
|
|
2021
Q3 | $148K | Buy |
20,848
+412
| +2% | +$4.07K | ﹤0.01% | 2479 |
|
|
2021
Q2 | $255K | Sell |
20,436
-393
| -2% | -$4.45K | ﹤0.01% | 2373 |
|
|
2021
Q1 | $371K | Hold |
20,829
| – | – | ﹤0.01% | 2165 |
|
|
2020
Q4 | $371K | Sell |
20,829
-87,566
| -81% | -$1.03M | ﹤0.01% | 2117 |
|
|
2020
Q3 | $1.07M | Buy |
108,395
+42,107
| +64% | +$455K | ﹤0.01% | 1572 |
|
|
2020
Q2 | $648K | Buy |
+66,288
| New | +$615K | ﹤0.01% | 1742 |
|
|
2020
Q1 | – | Sell |
-31,904
| Closed | -$267K | – | 2432 |
|
|
2019
Q4 | $267K | Buy |
+31,904
| New | +$293K | ﹤0.01% | 2181 |
|
|
2019
Q1 | – | Sell |
-191
| Closed | -$3K | – | 2971 |
|
|
2018
Q4 | $3K | Hold |
191
| – | – | ﹤0.01% | 2608 |
|
|
2018
Q3 | $3K | Buy |
191
+71
| +59% | +$1.08K | ﹤0.01% | 2473 |
|
|
2018
Q2 | $2K | Buy |
+120
| New | +$1.99K | ﹤0.01% | 3376 |
|
|
2016
Q2 | – | Sell |
-5,049
| Closed | -$31K | – | 2742 |
|
|
2016
Q1 | $31K | Buy |
5,049
+160
| +3% | +$961 | ﹤0.01% | 1967 |
|
|
2015
Q4 | $45K | Sell |
4,889
-100,889
| -95% | -$777K | ﹤0.01% | 1923 |
|
|
2015
Q3 | $597K | Buy |
105,778
+86,633
| +453% | +$714K | 0.01% | 1219 |
|
|
2015
Q2 | $213K | Sell |
19,145
-3,582
| -16% | -$46.2K | ﹤0.01% | 1375 |
|
|
2015
Q1 | $356K | Buy |
22,727
+2,523
| +12% | +$39K | ﹤0.01% | 1263 |
|
|
2014
Q4 | $307K | Buy |
+20,204
| New | +$245K | ﹤0.01% | 1282 |
|
Other funds holding SGMO
WA
SEI Investments's SGMO Position: Q3 2024 in Review
SEI Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 21,047 shares — an estimated $7.55K sold.
SEI Investments first reported a position in SGMO in Q4 2014 and held it in 26 quarters. The position peaked at $1.07M in Q3 2020. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.
- SEI Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
- SEI Investments sold 21,047 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $7.55K.
- SEI Investments first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and held it in 26 quarters.
- SEI Investments's SANGAMO THERAPEUTICS INC position peaked at $1.07M in Q3 2020.
- 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.
Based on SEI Investments's 13F filing for Q3 2024, filed 12 Nov 2024.